Cannabis Report
Home > Boards > US Listed > Biotechs > Amedica Corp. (AMDA)

That's standard procedure. Fully diluted OS is around

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
boston745 Member Profile
Member Level 
Followed By 10
Posts 2,971
Boards Moderated 1
Alias Born 07/10/15
160x600 placeholder
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 5/31/2018 5:14:29 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 5/18/2018 12:39:31 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/15/2018 5:51:35 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/15/2018 2:02:49 PM
Amedica Corporation Announces Closing of $15,000,000 Public Offering of Units Consisting of Convertible Preferred Stock and W... GlobeNewswire Inc. - 5/14/2018 4:26:16 PM
Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) Edgar (US Regulatory) - 5/11/2018 5:22:21 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 5/11/2018 3:16:28 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 5/11/2018 6:01:43 AM
Amedica Corporation Announces Pricing of $15,000,000 Public Offering of Units Consisting of Convertible Preferred Stock and W... GlobeNewswire Inc. - 5/10/2018 9:20:00 AM
Registration of Additional Securities (up to 20%) (s-1mef) Edgar (US Regulatory) - 5/10/2018 9:11:07 AM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 5/10/2018 6:37:02 AM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 5/9/2018 5:41:20 PM
Amedica Corporation Provides Update on its Clinical Studies GlobeNewswire Inc. - 5/8/2018 9:30:00 AM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 5/4/2018 5:22:49 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 5/1/2018 6:47:55 AM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 4/26/2018 6:16:50 AM
Amedica Announces Patent Grant for Silicon Nitride and Other Ceramic Materials GlobeNewswire Inc. - 3/30/2018 9:00:00 AM
Annual Report (10-k) Edgar (US Regulatory) - 3/29/2018 5:33:29 PM
Amedica Granted Extension by NASDAQ to Regain Compliance with NASDAQ Listing Rule GlobeNewswire Inc. - 3/15/2018 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/6/2018 1:45:53 PM
Amedica announces FDA Clearance of the Valeo C+CSC with Lumen Interbody Fusion Device GlobeNewswire Inc. - 3/6/2018 9:00:00 AM
AMEDICA Announces Participation in Australian Spine Conference GlobeNewswire Inc. - 2/27/2018 9:00:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 2/6/2018 6:02:13 AM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 2/5/2018 6:17:40 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/1/2018 9:01:37 AM
boston745 Member Level  Friday, 11/10/17 05:27:02 PM
Re: Dough Theory post# 12437
Post # of 16802 
That's standard procedure. Fully diluted OS is around 4.6m but requires a stock price over $12 to before 13 m warrants are exercised. The other exercise point is over $6.60.

Max potential cash into coffers is about $15 million.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist